Quadriceps vs. Hamstring Autograft for ACL Rupture
(SQuASH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines two methods for repairing a torn ACL (a ligament in the knee) in children and teenagers using their own tissue. It compares using a piece of the quadriceps tendon (from the front thigh) to the hamstring tendon (from the back thigh) to determine which is more effective. The study aims to identify which option results in fewer failures, a quicker return to sports, better knee function, and improved overall quality of life. Children and teenagers who play sports and require ACL surgery might be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance future ACL repair techniques for young athletes.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that using a piece of the quadriceps tendon for ACL surgery is safe and flexible. Patients generally tolerate it well, experiencing fewer issues like knee pain or difficulty kneeling compared to other graft types.
Studies indicate that the hamstring tendon is also mostly safe but may have a slightly higher chance of requiring another surgery later on.
Both the quadriceps and hamstring tendons are successfully used in ACL repairs, each offering distinct advantages and disadvantages. The quadriceps tendon is noted for its safety and reduced discomfort post-surgery, while the hamstring tendon remains popular despite a higher risk of additional procedures.12345Why are researchers excited about this trial?
Researchers are excited about using quadriceps and hamstring autografts for ACL rupture because they offer personalized options based on the patient's specific needs. Unlike traditional methods that rely on patellar tendon grafts, these autografts focus on soft tissue reconstruction, potentially reducing donor site morbidity and offering better flexibility in surgical techniques. Quadriceps grafts can be particularly appealing due to their robust size and strength, while hamstring grafts are valued for their minimal impact on the knee's extensor mechanism. This approach allows surgeons to tailor the treatment to each patient's anatomy and growth potential, potentially improving recovery outcomes.
What evidence suggests that this trial's treatments could be effective for ACL rupture?
This trial will compare quadriceps tendon autografts with hamstring tendon autografts for ACL reconstruction. Earlier studies showed that using the quadriceps tendon for ACL surgery resulted in fewer graft failures and better knee stability compared to the hamstring tendon. Research suggests that the quadriceps tendon also leads to less pain and quicker recovery at the donor site. Conversely, studies on the hamstring tendon have shown about an 11.7% chance of graft tearing after an average of 4.1 years. Both methods are effective, but the quadriceps tendon appears to offer slightly better early results, making it a promising option for ACL surgeries, especially in young people. Participants in this trial will be assigned to either the quadriceps tendon or hamstring tendon treatment arm to further evaluate these outcomes.678910
Who Is on the Research Team?
Darren de SA, MD
Principal Investigator
McMaster University
Are You a Good Fit for This Trial?
This trial is for boys and girls aged 10-18 who have had an ACL injury, speak the clinic's language, and can give informed consent. They must have been active in sports before their injury and be suitable for a specific type of knee surgery. Kids with very flexible joints, significant other health issues, or previous knee surgeries aren't eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ACL reconstruction using either soft-tissue quadriceps or hamstring autografts
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of knee function and return to sport
Long-term follow-up
Continued monitoring of knee function and re-operation rates
What Are the Treatments Tested in This Trial?
Interventions
- Quadriceps tendon autograft
- Soft tissue hamstring autograft
Quadriceps tendon autograft is already approved in European Union, United States for the following indications:
- Anterior cruciate ligament reconstruction in skeletally immature patients
- Anterior cruciate ligament reconstruction in pediatric patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Canadian Orthopaedic Foundation
Collaborator
The Physicians' Services Incorporated Foundation
Collaborator